$UGRO
urban-gro, Inc.

2023 Q3 Form 10-Q Financial Statement

#000170652423000080 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $20.93M $18.84M $16.28M
YoY Change 69.26% 15.7% 26.89%
Cost Of Revenue $18.08M $15.96M $12.78M
YoY Change 84.92% 24.91% 28.97%
Gross Profit $2.857M $2.875M $3.502M
YoY Change 10.19% -17.91% 19.83%
Gross Profit Margin 13.65% 15.26% 21.51%
Selling, General & Admin $5.723M $6.497M $5.123M
YoY Change -2.81% 26.83% 89.7%
% of Gross Profit 200.35% 226.01% 146.28%
Research & Development $0.00
YoY Change -100.0%
% of Gross Profit 0.0%
Depreciation & Amortization $131.1K $160.0K $371.6K
YoY Change -75.1% -56.94% 588.84%
% of Gross Profit 4.59% 5.57% 10.61%
Operating Expenses $5.965M $6.761M $5.429M
YoY Change -37.16% 24.54% 101.04%
Operating Profit -$3.109M -$3.886M -$1.927M
YoY Change -54.95% 101.69% -968.17%
Interest Expense -$20.47K $30.07K $39.62K
YoY Change -123.5% -24.1% -957.58%
% of Operating Profit
Other Income/Expense, Net -$307.6K -$1.611M $111.2K
YoY Change -83.23% -1548.89% -89.26%
Pretax Income -$3.416M -$5.497M -$1.816M
YoY Change -60.89% 202.76% -244.4%
Income Tax -$48.38K -$53.97K -$76.45K
% Of Pretax Income
Net Earnings -$3.368M -$5.443M -$1.739M
YoY Change -61.11% 212.96% -238.32%
Net Earnings / Revenue -16.09% -28.9% -10.68%
Basic Earnings Per Share -$0.29 -$0.50 -$0.17
Diluted Earnings Per Share -$0.29 -$0.50 -$0.17
COMMON SHARES
Basic Shares Outstanding 11.67M shares 10.94M shares 10.51M shares
Diluted Shares Outstanding 11.65M shares 10.95M shares 10.51M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.770M $8.559M $22.77M
YoY Change -74.36% -62.41% -54.87%
Cash & Equivalents $4.770M $8.559M $22.77M
Short-Term Investments
Other Short-Term Assets $42.76K $39.82K $32.18K
YoY Change -14.52% 23.72% -99.48%
Inventory $250.9K $300.5K $398.1K
Prepaid Expenses $1.411M $885.4K $761.7K
Receivables $18.34M $15.48M $14.90M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $34.76M $34.52M $44.76M
YoY Change -6.75% -22.86% -25.74%
LONG-TERM ASSETS
Property, Plant & Equipment $1.456M $1.333M $864.0K
YoY Change 75.34% 54.27% 626.31%
Goodwill $15.60M $15.57M $10.64M
YoY Change 28.64% 46.4%
Intangibles $4.635M $4.877M $4.887M
YoY Change 3.88% -0.21%
Long-Term Investments $0.00 $2.585M $4.210M
YoY Change -100.0% -38.6% 146.17%
Other Assets
YoY Change
Total Long-Term Assets $23.88M $26.76M $21.31M
YoY Change 12.86% 25.61% 656.8%
TOTAL ASSETS
Total Short-Term Assets $34.76M $34.52M $44.76M
Total Long-Term Assets $23.88M $26.76M $21.31M
Total Assets $58.64M $61.29M $66.06M
YoY Change 0.35% -7.23% 4.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $22.19M $18.55M $7.946M
YoY Change 240.98% 133.48% 250.69%
Accrued Expenses $4.074M $5.183M $3.381M
YoY Change -29.12% 53.3% 69.6%
Deferred Revenue $969.9K $1.940M $3.286M
YoY Change -49.74% -40.95%
Short-Term Debt $1.965M $1.941M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $31.95M $31.82M $18.18M
YoY Change 68.42% 75.01% 33.55%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $1.666M $1.823M $427.8K
YoY Change 92.99% 326.05%
Total Long-Term Liabilities $2.532M $2.737M $1.629M
YoY Change 29.15% 68.02%
TOTAL LIABILITIES
Total Short-Term Liabilities $31.95M $31.82M $18.18M
Total Long-Term Liabilities $2.532M $2.737M $1.629M
Total Liabilities $34.48M $34.56M $19.81M
YoY Change 64.74% 74.43% 45.52%
SHAREHOLDERS EQUITY
Retained Earnings -$52.07M -$48.71M -$25.28M
YoY Change 53.45% 92.7%
Common Stock $13.12K $13.06K $11.91K
YoY Change 9.8% 9.61%
Preferred Stock
YoY Change
Treasury Stock (at cost) $12.05M $12.05M $11.46M
YoY Change 3.48% 5.14%
Treasury Stock Shares 1.274M shares
Shareholders Equity $24.16M $26.73M $46.25M
YoY Change
Total Liabilities & Shareholders Equity $58.64M $61.29M $66.06M
YoY Change 0.35% -7.23% 4.72%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$3.368M -$5.443M -$1.739M
YoY Change -61.11% 212.96% -238.32%
Depreciation, Depletion And Amortization $131.1K $160.0K $371.6K
YoY Change -75.1% -56.94% 588.84%
Cash From Operating Activities -$5.862M $3.615M -$1.197M
YoY Change 44.23% -401.95% -219.9%
INVESTING ACTIVITIES
Capital Expenditures $226.5K $92.87K -$342.3K
YoY Change -286.05% -127.13% 3439.71%
Acquisitions
YoY Change
Other Investing Activities $2.326M $0.00 -$2.709M
YoY Change -100.0%
Cash From Investing Activities $2.100M -$92.87K -$3.051M
YoY Change 1625.12% -96.96% 31455.74%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -25.46K -2.290M -36.00K
YoY Change -88.42% 6262.03% -92.29%
NET CHANGE
Cash From Operating Activities -5.862M 3.615M -1.197M
Cash From Investing Activities 2.100M -92.87K -3.051M
Cash From Financing Activities -25.46K -2.290M -36.00K
Net Change In Cash -3.788M 1.232M -4.285M
YoY Change -9.01% -128.75% -920.9%
FREE CASH FLOW
Cash From Operating Activities -$5.862M $3.615M -$1.197M
Capital Expenditures $226.5K $92.87K -$342.3K
Free Cash Flow -$6.089M $3.522M -$854.9K
YoY Change 54.43% -511.99% -184.8%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13056409 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11606576 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
12221 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
84882982 usd
CY2023Q2 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1449833 shares
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
12045542 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-38117897 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34731764 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62065552 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18837544 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16281503 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
15962910 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
12779557 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
2874634 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
3501946 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5874346 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4240658 usd
CY2023Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
622547 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
882000 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
264165 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
306225 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
6761058 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
5428883 usd
us-gaap Operating Expenses
OperatingExpenses
14649576 usd
us-gaap Operating Expenses
OperatingExpenses
11198682 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3886424 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1926937 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-8933094 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2794716 usd
CY2023Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
44989 usd
CY2022Q2 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
7658 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
118205 usd
us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
15317 usd
CY2023Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
75061 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
47275 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
148191 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
127126 usd
CY2023Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2022Q2 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
160232 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
CY2023Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1500000 usd
CY2022Q2 us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1500000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-140947 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
71563 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-143739 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
62874 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1610875 usd
CY2022Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
111180 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1773985 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
174683 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5497299 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1815757 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-10707079 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2620033 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-53966 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-76453 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-119097 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-184512 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5443333 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1739304 usd
us-gaap Net Income Loss
NetIncomeLoss
-10587982 usd
us-gaap Net Income Loss
NetIncomeLoss
-2435521 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5443333 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1739304 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-10587982 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2435521 usd
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.50
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.50
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.17
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.17
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.97
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.97
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.23
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.23
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10945978 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10945978 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10508972 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10508972 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10859820 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10859820 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10527975 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
10527975 shares
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
479641 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
191919 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-5144649 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
30258675 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
622547 usd
CY2023Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
1292683 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-5443333 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
26730572 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
48167330 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
882000 usd
CY2022Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
3773177 usd
CY2022Q1 ugro Stock Issued During Period Value Stock Exercised
StockIssuedDuringPeriodValueStockExercised
28797 usd
CY2022Q1 ugro Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
0 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-696217 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
44608733 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
882000 usd
CY2022Q2 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
2500000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1739304 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
46251429 usd
us-gaap Net Income Loss
NetIncomeLoss
-10587982 usd
us-gaap Net Income Loss
NetIncomeLoss
-2435521 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
828232 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
589835 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-119097 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-184512 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1102188 usd
us-gaap Share Based Compensation
ShareBasedCompensation
1764000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
-1500000 usd
us-gaap Gain Loss Related To Litigation Settlement
GainLossRelatedToLitigationSettlement
0 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
160232 usd
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-472277 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
54942 usd
ugro Increase Decrease In Accounts Receivable And Contract Receivables
IncreaseDecreaseInAccountsReceivableAndContractReceivables
4424814 usd
ugro Increase Decrease In Accounts Receivable And Contract Receivables
IncreaseDecreaseInAccountsReceivableAndContractReceivables
-663955 usd
ugro Increase Decrease In Prepaid Expense Other Assets And Property And Equipment
IncreaseDecreaseInPrepaidExpenseOtherAssetsAndPropertyAndEquipment
-1030205 usd
ugro Increase Decrease In Prepaid Expense Other Assets And Property And Equipment
IncreaseDecreaseInPrepaidExpenseOtherAssetsAndPropertyAndEquipment
-6275332 usd
ugro Increase Decrease In Accounts Payable Contract Liabilities And Accrued Liabilities
IncreaseDecreaseInAccountsPayableContractLiabilitiesAndAccruedLiabilities
11289944 usd
ugro Increase Decrease In Accounts Payable Contract Liabilities And Accrued Liabilities
IncreaseDecreaseInAccountsPayableContractLiabilitiesAndAccruedLiabilities
-1320152 usd
ugro Increase Decrease In Business Combination Contingent Consideration Arrangements Liability
IncreaseDecreaseInBusinessCombinationContingentConsiderationArrangementsLiability
-917699 usd
ugro Increase Decrease In Business Combination Contingent Consideration Arrangements Liability
IncreaseDecreaseInBusinessCombinationContingentConsiderationArrangementsLiability
0 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-360787 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-163054 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-630767 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-10059378 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-658068 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4924437 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0 usd
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
2709148 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
226700 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
374630 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-226700 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3083778 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
28797 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3773177 usd
ugro Finance Lease Payments
FinanceLeasePayments
88299 usd
ugro Finance Lease Payments
FinanceLeasePayments
72000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
479457 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1996298 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
0 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2564054 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3816380 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3448822 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-11824595 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
12008003 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34592190 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
8559181 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
22767595 usd
us-gaap Interest Paid Net
InterestPaidNet
13402 usd
us-gaap Interest Paid Net
InterestPaidNet
15317 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
134252 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
52733 usd
us-gaap Stock Issued1
StockIssued1
0 usd
us-gaap Stock Issued1
StockIssued1
2500000 usd
ugro Operating Lease Right Of Use Assets And Liabilities Extension
OperatingLeaseRightOfUseAssetsAndLiabilitiesExtension
295631 usd
ugro Operating Lease Right Of Use Assets And Liabilities Extension
OperatingLeaseRightOfUseAssetsAndLiabilitiesExtension
55297 usd
CY2023Q2 us-gaap Notes Payable Current
NotesPayableCurrent
1941188 usd
CY2022Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3832682 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
666585 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y4M24D
us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In preparing condensed consolidated financial statements in conformity with GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of assets and liabilities at the date of the condensed consolidated financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include estimated revenues earned under construction design-build contracts; estimated useful lives and potential impairment of long-lived assets, intangibles and goodwill; inventory write-offs; allowance for deferred tax assets; and allowance for bad debt.</span></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Reclassification</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior year amounts have been reclassified for consistency with the current year presentation. These reclassifications had no effect on the reported results of operations.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Balance Sheet Classifications</span></div><div style="margin-top:10pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company includes in current assets and liabilities the following amounts that are in connection with construction contracts that may extend beyond one year: contract assets and contract liabilities (including retainage invoiced to customers contingent upon anything other than the passage of time), capitalized costs to fulfill contracts, retainage payable to sub-contractors and accrued losses on uncompleted contracts. A one-year time period is used to classify all other current assets and liabilities when not otherwise prescribed by the applicable accounting principles.</span></div>
CY2023Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
18837544 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
16281503 usd
CY2023Q2 ugro Revenue From Contract With Customer Excluding Assessed Tax Relative Percent
RevenueFromContractWithCustomerExcludingAssessedTaxRelativePercent
1
CY2022Q2 ugro Revenue From Contract With Customer Excluding Assessed Tax Relative Percent
RevenueFromContractWithCustomerExcludingAssessedTaxRelativePercent
1
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
35602930 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
37334371 usd
ugro Revenue From Contract With Customer Excluding Assessed Tax Relative Percent
RevenueFromContractWithCustomerExcludingAssessedTaxRelativePercent
1
ugro Revenue From Contract With Customer Excluding Assessed Tax Relative Percent
RevenueFromContractWithCustomerExcludingAssessedTaxRelativePercent
1
CY2023Q2 ugro Revenue Recognized In Excess Of Amounts Paid Or Payable Contract Receivables To The Company On Uncompleted Contracts Contract Asset Excluding Retainage
RevenueRecognizedInExcessOfAmountsPaidOrPayableContractReceivablesToTheCompanyOnUncompletedContractsContractAssetExcludingRetainage
6702100 usd
CY2022Q4 ugro Revenue Recognized In Excess Of Amounts Paid Or Payable Contract Receivables To The Company On Uncompleted Contracts Contract Asset Excluding Retainage
RevenueRecognizedInExcessOfAmountsPaidOrPayableContractReceivablesToTheCompanyOnUncompletedContractsContractAssetExcludingRetainage
2874141 usd
CY2023Q2 ugro Retainage Included In Contract Assets Due To Being Conditional On Something Other Than Solely Passage Of Time
RetainageIncludedInContractAssetsDueToBeingConditionalOnSomethingOtherThanSolelyPassageOfTime
246317 usd
CY2022Q4 ugro Retainage Included In Contract Assets Due To Being Conditional On Something Other Than Solely Passage Of Time
RetainageIncludedInContractAssetsDueToBeingConditionalOnSomethingOtherThanSolelyPassageOfTime
130141 usd
CY2023Q2 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
6948417 usd
CY2022Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
3004282 usd
CY2023Q2 ugro Payments Received Or Receivable Contract Receivables In Excess Of Revenue Recognized On Uncompleted Contracts Contract Liability Excluding Retainage
PaymentsReceivedOrReceivableContractReceivablesInExcessOfRevenueRecognizedOnUncompletedContractsContractLiabilityExcludingRetainage
3312396 usd
CY2022Q4 ugro Payments Received Or Receivable Contract Receivables In Excess Of Revenue Recognized On Uncompleted Contracts Contract Liability Excluding Retainage
PaymentsReceivedOrReceivableContractReceivablesInExcessOfRevenueRecognizedOnUncompletedContractsContractLiabilityExcludingRetainage
1294452 usd
CY2023Q2 ugro Contract With Customer Liability Including Retainage
ContractWithCustomerLiabilityIncludingRetainage
32436 usd
CY2022Q4 ugro Contract With Customer Liability Including Retainage
ContractWithCustomerLiabilityIncludingRetainage
0 usd
CY2023Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
3344832 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
1294452 usd
CY2023Q2 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
14242229 usd
CY2022Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss Current
ContractWithCustomerReceivableAfterAllowanceForCreditLossCurrent
12466180 usd
CY2023Q2 us-gaap Nontrade Receivables
NontradeReceivables
1232917 usd
CY2022Q4 us-gaap Nontrade Receivables
NontradeReceivables
2914112 usd
CY2022Q4 ugro Miscellaneous Nontrade Receivable
MiscellaneousNontradeReceivable
514112 usd
CY2022Q4 ugro Legal Settlement Receivable
LegalSettlementReceivable
2400000 usd
CY2023Q1 us-gaap Proceeds From Legal Settlements
ProceedsFromLegalSettlements
2400000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1335817 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
5422396 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
28291 usd
CY2022Q4 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
28291 usd
CY2022Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6786504 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1335817 usd
CY2022Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
5450687 usd
CY2023Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
264165 usd
CY2023Q2 ugro Vendor Prepayments Current
VendorPrepaymentsCurrent
2314800 usd
CY2022Q4 ugro Vendor Prepayments Current
VendorPrepaymentsCurrent
2459389 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
885416 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1346430 usd
CY2023Q2 ugro Prepaid Inventory Current
PrepaidInventoryCurrent
300520 usd
CY2022Q4 ugro Prepaid Inventory Current
PrepaidInventoryCurrent
320372 usd
CY2023Q2 us-gaap Other Assets Current
OtherAssetsCurrent
39818 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
38769 usd
CY2023Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3540554 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4164960 usd
CY2022Q2 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
306225 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
574184 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
468725 usd
CY2023Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
867409 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
667269 usd
CY2023Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1332908 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1307146 usd
CY2023Q2 us-gaap Depreciation
Depreciation
159995 usd
CY2022Q2 us-gaap Depreciation
Depreciation
65335 usd
us-gaap Depreciation
Depreciation
254048 usd
us-gaap Depreciation
Depreciation
121113 usd
CY2022Q4 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2559307 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Upward Price Adjustment Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueUpwardPriceAdjustmentAnnualAmount
25657 usd
CY2023Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueAmount
2584964 usd
CY2023Q2 us-gaap Goodwill
Goodwill
15572050 usd
CY2022Q4 us-gaap Goodwill
Goodwill
15572050 usd
CY2023Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2022Q2 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6758213 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1910001 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4848212 usd
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
28291 usd
CY2023Q2 us-gaap Indefinite Lived Intangible Assets Excluding Goodwill
IndefiniteLivedIntangibleAssetsExcludingGoodwill
28291 usd
CY2023Q2 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
6786504 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1910001 usd
CY2023Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4876503 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
6758213 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
491841 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
959788 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
959788 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
918205 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
693555 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
825035 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4848212 usd
CY2023Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
527690 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
515858 usd
CY2023Q2 ugro Litigation Liability Current
LitigationLiabilityCurrent
1500000 usd
CY2022Q4 ugro Litigation Liability Current
LitigationLiabilityCurrent
0 usd
CY2023Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1134304 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
639614 usd
CY2023Q2 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
66004 usd
CY2022Q4 us-gaap Other Employee Related Liabilities Current And Noncurrent
OtherEmployeeRelatedLiabilitiesCurrentAndNoncurrent
262599 usd
CY2023Q2 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1955453 usd
CY2022Q4 us-gaap Sales And Excise Tax Payable Current
SalesAndExciseTaxPayableCurrent
1778890 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
5183451 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3196961 usd
CY2023Q2 ugro Lessee Operating Lease Number Of Leases
LesseeOperatingLeaseNumberOfLeases
8 lease
CY2023Q2 ugro Lessee Finance Lease Number Of Leases
LesseeFinanceLeaseNumberOfLeases
1 lease
CY2023Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.080
CY2023Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.080
ugro Share Based Compensation Arrangement By Share Based Payment Award Options Forfeited Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedWeightedAverageRemainingContractualTerm
P0Y
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
9.39
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
0 shares
ugro Share Based Compensation Arrangement By Share Based Payment Award Options Exercised Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedWeightedAverageRemainingContractualTerm
P0Y
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2440569 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
2645598 usd
CY2023Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
617815 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
600816 usd
CY2023Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1822754 usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2044782 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
417885 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
754076 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
573133 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
404751 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
346812 usd
CY2023Q2 ugro Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
335903 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
2832560 usd
CY2023Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
391991 usd
CY2023Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
2440569 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
669388 shares
CY2022 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y10M24D
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.77
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
ugro Share Based Compensation Arrangement By Share Based Payment Award Options Issued Weighted Average Remaining Contractual Term1
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsIssuedWeightedAverageRemainingContractualTerm1
P0Y
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
2803 shares
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.77
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
618651 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y3M18D
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.30
CY2021Q2 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
5000000 usd
CY2021Q2 us-gaap Stock Repurchase Program Period In Force1
StockRepurchaseProgramPeriodInForce1
P12M
CY2022Q1 ugro Stock Repurchase Program Increase To Authorized Amount
StockRepurchaseProgramIncreaseToAuthorizedAmount
2000000 usd
CY2022Q1 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
7000000 usd
CY2022Q1 ugro Stock Repurchase Program Increase To Authorized Amount
StockRepurchaseProgramIncreaseToAuthorizedAmount
1500000 usd
CY2022Q3 ugro Stock Repurchase Program Increase To Authorized Amount
StockRepurchaseProgramIncreaseToAuthorizedAmount
2000000 usd
CY2022Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
10500000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1099833 shares
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
8.25
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
9100000 usd
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
0 shares
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
419088 shares
us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
9.02
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3800000 usd
CY2023Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
1400000 usd
CY2021Q1 us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
350000 shares
CY2021Q1 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
8.50
CY2021Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
3000000 usd
CY2022Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
311499 shares
CY2022Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
12.32
ugro Class Of Warrant Or Right Exercised
ClassOfWarrantOrRightExercised
0 shares
ugro Class Of Warrant Or Right Exercised Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisedExercisePriceOfWarrantsOrRights
0
ugro Class Of Warrant Or Right Expired
ClassOfWarrantOrRightExpired
1000 shares
ugro Class Of Warrant Or Right Expired Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExpiredExercisePriceOfWarrantsOrRights
6.00
CY2023Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
310499 shares
CY2023Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
12.34
CY2023Q2 ugro Class Of Warrant Or Right Exercisable
ClassOfWarrantOrRightExercisable
310499 shares
CY2023Q2 ugro Class Of Warrant Or Right Excisable Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExcisableExercisePriceOfWarrantsOrRights
12.34
ugro Class Of Warrant Or Right Weighted Average Life
ClassOfWarrantOrRightWeightedAverageLife
P2Y2M12D
CY2023Q2 ugro Class Of Warrant Or Right Exercisable Intrinsic Value
ClassOfWarrantOrRightExercisableIntrinsicValue
0 usd
CY2023Q2 ugro Class Of Warrant Or Right Outstanding Intrinsic Value
ClassOfWarrantOrRightOutstandingIntrinsicValue
0 usd

Files In Submission

Name View Source Status
ugro-20230630_cal.xml Edgar Link unprocessable
0001706524-23-000080-index-headers.html Edgar Link pending
0001706524-23-000080-index.html Edgar Link pending
0001706524-23-000080.txt Edgar Link pending
0001706524-23-000080-xbrl.zip Edgar Link pending
a063023-exx311.htm Edgar Link pending
a063023-exx312.htm Edgar Link pending
a063023-exx321.htm Edgar Link pending
crest-finalsettlementagr.htm Edgar Link pending
crest-finalsettlementagr001.jpg Edgar Link pending
crest-finalsettlementagr002.jpg Edgar Link pending
crest-finalsettlementagr003.jpg Edgar Link pending
crest-finalsettlementagr004.jpg Edgar Link pending
crest-finalsettlementagr005.jpg Edgar Link pending
crest-finalsettlementagr006.jpg Edgar Link pending
ex-102rsugrantnotice.htm Edgar Link pending
ex-10x3rsuawardagreement.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
ugro-20230630.htm Edgar Link pending
ugro-20230630.xsd Edgar Link pending
ugro-20230630_def.xml Edgar Link unprocessable
ugro-20230630_htm.xml Edgar Link completed
ugro-20230630_lab.xml Edgar Link unprocessable
ugro-20230630_pre.xml Edgar Link unprocessable